@prefix ins: <http://data.loterre.fr/ark:/67375/INS> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .

ins:-F116QJTC-1
  skos:definition "Once a dose or range of doses is determined, the next goal is to evaluate whether the drug has any biological activity or effect. Phase II trials are performed on larger groups (50–300) and are designed to assess how well the drug works, as well as to continue Phase I safety assessments in a larger group of volunteers and patients."@en ;
  a skos:Concept ;
  skos:inScheme ins: ;
  skos:broader ins:-SZT9L196-B ;
  skos:prefLabel "étude de phase II"@fr, "phase 2"@en ;
  skos:altLabel "phase II study"@en ;
  skos:exactMatch <https://en.wikipedia.org/wiki/Phases_of_clinical_research#Phase_II> .

ins: a skos:ConceptScheme .
ins:-SZT9L196-B
  skos:prefLabel "étude"@fr, "study"@en ;
  a skos:Concept ;
  skos:narrower ins:-F116QJTC-1 .